Jump to: navigation, search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Mebutamate


Most recent articles on Mebutamate

Most cited articles on Mebutamate

Review articles on Mebutamate

Articles on Mebutamate in N Eng J Med, Lancet, BMJ


Powerpoint slides on Mebutamate

Images of Mebutamate

Photos of Mebutamate

Podcasts & MP3s on Mebutamate

Videos on Mebutamate

Evidence Based Medicine

Cochrane Collaboration on Mebutamate

Bandolier on Mebutamate

TRIP on Mebutamate

Clinical Trials

Ongoing Trials on Mebutamate at Clinical

Trial results on Mebutamate

Clinical Trials on Mebutamate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mebutamate

NICE Guidance on Mebutamate


FDA on Mebutamate

CDC on Mebutamate


Books on Mebutamate


Mebutamate in the news

Be alerted to news on Mebutamate

News trends on Mebutamate


Blogs on Mebutamate


Definitions of Mebutamate

Patient Resources / Community

Patient resources on Mebutamate

Discussion groups on Mebutamate

Patient Handouts on Mebutamate

Directions to Hospitals Treating Mebutamate

Risk calculators and risk factors for Mebutamate

Healthcare Provider Resources

Symptoms of Mebutamate

Causes & Risk Factors for Mebutamate

Diagnostic studies for Mebutamate

Treatment of Mebutamate

Continuing Medical Education (CME)

CME Programs on Mebutamate


Mebutamate en Espanol

Mebutamate en Francais


Mebutamate in the Marketplace

Patents on Mebutamate

Experimental / Informatics

List of terms related to Mebutamate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Mebutamate (Capla, Dormate) is an anxiolytic and sedative drug with antihypertensive effects of the carbamate class. It has effects comparable to those of barbiturates such as secobarbital, but is only around 1/3 the potency of secobarbital as a sedative. Side effects include dizziness and headaches. Mebutamate is one of many GABAergic drugs which act via allosteric agonism of the GABAA receptor at the β-subreceptor similair to barbiturates. In contrast, benzodiazepines act at the α-subreceptor. As such, carbamates and barbiturates, possess analgesic properties which the benzodiazepine class of drugs do not. Other carbamates with the same mechanism of action and pharmacological properties include meprobamate, carisoprodol, felbamate, and tybamate).